Sage Capital Advisors,Llc Johnson & Johnson Transaction History

Sage Capital Advisors,Llc

$344 Million
Q2 2024

A detailed history of Sage Capital Advisors,Llc transactions in Johnson & Johnson stock. As of the latest transaction made, Sage Capital Advisors,Llc holds 42,785 shares of JNJ stock, worth $7.04 Million. This represents 1.82% of its overall portfolio holdings.

Number of Shares

42,785

Previous 42,493 0.69%

Holding current value

$7.04 Million

Previous $6.72 Million 6.96%

% of portfolio

1.82%

Previous 1.97%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	BUY	$144.38 - $157.78 $42,158 - $46,071	292 Added 0.69%	42,785 $6.25 Million
Q1 2024 Apr 15, 2024	BUY	$155.22 - $162.74 $116,415 - $122,055	750 Added 1.8%	42,493 $6.72 Million
Q4 2023 Jan 09, 2024	BUY	$145.6 - $158.88 $46,155 - $50,364	317 Added 0.77%	41,743 $6.54 Million
Q3 2023 Oct 12, 2023	BUY	$155.75 - $174.48 $41,429 - $46,411	266 Added 0.65%	41,426 $6.45 Million
Q2 2023 Jul 12, 2023	BUY	$154.35 - $166.11 $325,832 - $350,658	2,111 Added 5.41%	41,160 $6.81 Million
Q1 2023 Apr 11, 2023	BUY	$151.05 - $180.26 $402,095 - $479,852	2,662 Added 7.32%	39,049 $6.05 Million
Q4 2022 Jan 19, 2023	BUY	$160.2 - $179.79 $394,732 - $443,002	2,464 Added 7.26%	36,387 $0
Q3 2022 Oct 17, 2022	BUY	$161.33 - $179.52 $363,799 - $404,817	2,255 Added 7.12%	33,923 $5.54 Million
Q2 2022 Jul 06, 2022	BUY	$168.19 - $186.01 $7,736 - $8,556	46 Added 0.15%	31,668 $5.62 Million
Q1 2022 Apr 11, 2022	BUY	$158.14 - $179.59 $42,065 - $47,770	266 Added 0.85%	31,622 $5.76 Million
Q4 2021 Jan 20, 2022	BUY	$155.93 - $173.01 $585,205 - $649,306	3,753 Added 13.6%	31,356 $5.22 Million
Q3 2021 Oct 26, 2021	SELL	$161.5 - $179.47 $55,394 - $61,558	-343 Reduced 1.23%	27,603 $4.46 Million
Q2 2021 Jul 22, 2021	BUY	$159.48 - $171.07 $169,686 - $182,018	1,064 Added 3.96%	27,946 $4.74 Million
Q1 2021 May 04, 2021	SELL	$153.07 - $170.48 $7,959 - $8,864	-52 Reduced 0.19%	26,882 $4.42 Million
Q4 2020 Feb 08, 2021	BUY	$137.11 - $157.38 $959 - $1,101	7 Added 0.03%	26,934 $4.36 Million
Q3 2020 Oct 29, 2020	SELL	$140.38 - $153.83 $9,405 - $10,306	-67 Reduced 0.25%	26,927 $4.01 Million
Q2 2020 Jul 13, 2020	SELL	$128.81 - $155.51 $6,698 - $8,086	-52 Reduced 0.19%	26,994 $3.8 Million
Q1 2020 Apr 17, 2020	BUY	$111.14 - $153.99 $82,021 - $113,644	738 Added 2.81%	27,046 $3.55 Million
Q4 2019 Jan 16, 2020	BUY	$127.5 - $146.44 $18,615 - $21,380	146 Added 0.56%	26,308 $3.84 Million
Q3 2019 Oct 17, 2019	SELL	$126.95 - $142.14 $278,909 - $312,281	-2,197 Reduced 7.75%	26,162 $3.39 Million
Q2 2019 Jul 31, 2019	SELL	$131.15 - $144.24 $1.31 Million - $1.44 Million	-10,014 Reduced 26.1%	28,359 $3.75 Million
Q1 2019 Jul 31, 2019	SELL	$125.72 - $139.79 $1.12 Million - $1.24 Million	-8,906 Reduced 18.84%	38,373 $5.36 Million
Q1 2019 Apr 23, 2019	BUY	$125.72 - $139.79 $1.11 Million - $1.24 Million	8,856 Added 23.05%	47,279 $6.61 Million
Q4 2018 Jul 31, 2019	SELL	$122.84 - $147.84 $1.09 Million - $1.32 Million	-8,906 Reduced 18.82%	38,423 $4.96 Million
Q4 2018 Feb 11, 2019	BUY	$122.84 - $147.84 $107,485 - $129,360	875 Added 1.88%	47,329 $6.11 Million
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $28,814 - $33,862	237 Added 0.51%	46,454 $6.42 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $1,552 - $1,712	-13 Reduced 0.03%	46,217 $5.61 Million
Q1 2018 May 01, 2018	BUY	$125.1 - $148.14 $8,381 - $9,925	67 Added 0.15%	46,230 $5.92 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $11,809 - $12,925	90 Added 0.2%	46,163 $6.45 Million
Q3 2017 Jul 31, 2019	SELL	$129.47 - $135.38 $20,715 - $21,660	-160 Reduced 0.35%	46,073 $5.99 Million
Q3 2017 Nov 30, 2017	SELL	$129.47 - $135.38 $49,975 - $52,256	-386 Reduced 0.83%	46,233 $6.01 Million
Q2 2017 Jul 31, 2019	SELL	N/A	-160 Reduced 0.34%	46,619 $6.17 Million
Q2 2017 Aug 08, 2017	BUY	N/A	46,779	46,779 $6.19 Million

Others Institutions Holding JNJ

# of Institutions

4,157

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $430B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Capital Advisors,Llc, based on Form 13F filings with the SEC.

News

Stay updated on Sage Capital Advisors,Llc with notifications on news.

Account

Sage Capital Advisors,Llc Johnson & Johnson Transaction History